{
  "company": {
    "name": "Nava Therapeutics",
    "website": "https://navatx.com/",
    "record": "https://startuphistory.org/c/navatx.com"
  },
  "status": null,
  "history_since": "2021-12-17T07:51:17.000Z",
  "baseline": {
    "snapshot_id": "b3c1845d15cf05103efbac54cdf082d380e7e110737487425bf9e5b6c20e76f2",
    "observed_at": "2021-12-17T07:51:17.000Z",
    "headline": "navatx.com",
    "description": "The premium domain name navatx.com is available for sale!",
    "evidence": "https://web.archive.org/web/20211217075117/http://navatx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:47:03.732Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2021-12-17T07:51:17.000Z",
      "variants": [
        {
          "headline": "navatx.com",
          "subhead": "The premium domain name navatx.com is available for sale!",
          "observed_at": "2021-12-17T07:51:17.000Z",
          "evidence": "https://web.archive.org/web/20211217075117/http://navatx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "navatx.com",
      "subhead": "The premium domain name navatx.com is available for sale!",
      "from": "2021-12-17T07:51:17.000Z",
      "to": "2021-12-17T07:51:17.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20211217075117/http://navatx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2021-12-17T07:51:17.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:47:03.732Z",
      "variants": [
        {
          "headline": "RNA therapeutics. Beyond limits.",
          "subhead": "Nava is building a new class of genetic medicines harnessing novel lipid nanoparticles (LNPs) able to deliver RNA therapeutics to organs and cellular targets with unparalleled precision and efficiency",
          "observed_at": "2026-11-06T17:47:03.732Z",
          "evidence": "https://navatx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "RNA therapeutics. Beyond limits.",
      "subhead": "Nava is building a new class of genetic medicines harnessing novel lipid nanoparticles (LNPs) able to deliver RNA therapeutics to organs and cellular targets with unparalleled precision and efficiency",
      "from": "2026-11-06T17:47:03.732Z",
      "to": "2026-11-06T17:47:03.732Z",
      "captures": 1,
      "evidence": "https://navatx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T17:47:03.732Z"
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "NanoVation Therapeutics",
      "record": "https://startuphistory.org/c/nanovationtx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "NanoCell Therapeutics",
      "record": "https://startuphistory.org/c/nanocelltx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Addition Therapeutics",
      "record": "https://startuphistory.org/c/additiontx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "Mana.bio",
      "record": "https://startuphistory.org/c/mana.bio",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "NV Therapeutics",
      "record": "https://startuphistory.org/c/nvtx.bio",
      "basis": "description_similarity",
      "category": null
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Nava Therapeutics” company record, https://startuphistory.org/c/navatx.com"
}